SAFETY, IMMUNOGENICITY AND IMPACT ON PARASITE MULTIPLICATION RATES OF THE CANDIDATE BLOOD-STAGE VACCINE AMA1-C1/ALHYDROGEL WITH THE NOVEL ADJUVANT CPG 7909 AGAINST BLOOD-STAGE MALARIA CHALLENGE IN HEALTHY MALARIA-NAIVE VOLUNTEERS

SAFETY, IMMUNOGENICITY AND IMPACT ON PARASITE MULTIPLICATION RATES OF THE CANDIDATE BLOOD-STAGE VACCINE AMA1-C1/ALHYDROGEL WITH THE NOVEL ADJUVANT CPG 7909 AGAINST BLOOD-STAGE MALARIA CHALLENGE IN HEALTHY MALARIA-NAIVE VOLUNTEERS

Opis bibliograficzny
Główni autorzy:	Duncan, C, Sheehy, S, Ewer, K, Douglas, A, Halstead, F, Edwards, N, Collins, K, Lillie, P, Poulton, I, Hunt-Cooke, A, Lawrie, A, Draper, S, Gilbert, S, Fay, M, Miura, K, Long, C, Wu, Y, Hill, A, Ellis, R
Format:	Conference item
Wydane:	2010

Podobne zapisy

Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909.
od: Duncan, C, i wsp.
Wydane: (2011)

Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909.
od: Christopher J A Duncan, i wsp.
Wydane: (2011-01-01)

Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malaria.
od: Gregory E D Mullen, i wsp.
Wydane: (2008-08-01)

Phase 1 study in malaria naïve adults of BSAM2/Alhydrogel®+CPG 7909, a blood stage vaccine against P. falciparum malaria.
od: Ruth D Ellis, i wsp.
Wydane: (2012-01-01)

Phase 1 trial of the Plasmodium falciparum blood stage vaccine MSP1(42)-C1/Alhydrogel with and without CPG 7909 in malaria naïve adults.
od: Ruth D Ellis, i wsp.
Wydane: (2010-01-01)

Viral vectored blood-stage malaria vaccines induce B cell responses in humans that can be boosted by controlled malaria infection
od: Elias, S, i wsp.
Wydane: (2014)

Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection.
od: Elias, S, i wsp.
Wydane: (2013)

ChAd63-MVA-vectored blood-stage Malaria vaccines targeting MSP1 and AMA1: Assessment of efficacy against mosquito bite challenge in humans
od: Sheehy, S, i wsp.
Wydane: (2012)

ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.
od: Sheehy, S, i wsp.
Wydane: (2012)

CLINICAL EVALUATION OF NEW VIRAL VECTORED VACCINES TARGETING THE PLASMODIUM FALCIPARUM BLOOD-STAGE ANTIGENS; MSP1 AND AMA1
od: Sheehy, S, i wsp.
Wydane: (2011)

Challenges of assessing the clinical efficacy of asexual blood-stage Plasmodium falciparum malaria vaccines.
od: Sheehy, S, i wsp.
Wydane: (2013)

Demonstration of the blood-stage controlled human malaria infection model to assess efficacy of the Plasmodium falciparum AMA1 vaccine FMP2.1/AS01
od: Payne, R, i wsp.
Wydane: (2016)

Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors.
od: Sheehy, S, i wsp.
Wydane: (2012)

Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial.
od: Hodgson, S, i wsp.
Wydane: (2014)

Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian children.
od: Alassane Dicko, i wsp.
Wydane: (2008-02-01)

Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02.
od: Meta Roestenberg, i wsp.
Wydane: (2008-01-01)

Blood-stage malaria vaccines - recent progress and future challenges.
od: Goodman, A, i wsp.
Wydane: (2010)

Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure
od: Biswas, S, i wsp.
Wydane: (2014)

Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection.
od: Elias, S, i wsp.
Wydane: (2014)

Controlled human blood stage malaria infection: current status and potential applications.
od: Duncan, C, i wsp.
Wydane: (2012)

Complete protective immunity against blood-stage malaria induced by heterologous prime-boost vaccination
od: Draper, S, i wsp.
Wydane: (2005)

Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity”
od: Ewer, K, i wsp.
Wydane: (2015)

Phase Ia clinical evaluation of the plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors
od: Sheehy, S, i wsp.
Wydane: (2011)

Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.
od: Sheehy, S, i wsp.
Wydane: (2011)

Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference.
od: Forbes, E, i wsp.
Wydane: (2011)

Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure.
od: Sumi Biswas, i wsp.
Wydane: (2014-01-01)

Developing novel blood-stage malaria vaccines
od: Douglas, AD
Wydane: (2015)

An essential malaria protein defines the architecture of blood-stage and transmission-stage parasites
od: Sabrina Absalon, i wsp.
Wydane: (2016-04-01)

Role of distinct DC subsets in blood-stage malaria immunity
od: Tamara A. Nair
Wydane: (2012)

Anaemia in a phase 2 study of a blood stage falciparum malaria vaccine
od: Guindo Aldiouma, i wsp.
Wydane: (2011-01-01)

The evolutionary consequences of blood-stage vaccination on the rodent malaria Plasmodium chabaudi.
od: Victoria C Barclay, i wsp.
Wydane: (2012-01-01)

Prime and target immunization protects against liver-stage malaria in mice
od: Gola, A, i wsp.
Wydane: (2018)

Longevity of the immune response and memory to blood-stage malaria infection.
od: Achtman, A, i wsp.
Wydane: (2005)

Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria.
od: Pukrittayakamee, S, i wsp.
Wydane: (1994)

New antigens for a multicomponent blood-stage malaria vaccine.
od: Osier, F, i wsp.
Wydane: (2014)

Deconvoluting heme biosynthesis to target blood-stage malaria parasites
od: Paul A Sigala, i wsp.
Wydane: (2015-07-01)

Mouse Models for Unravelling Immunology of Blood Stage Malaria
od: Adesola C. Olatunde, i wsp.
Wydane: (2022-09-01)

Blood-Stage Malaria Vaccines : MSP1 19
od: Chakrit Hirunpetcharat
Wydane: (2015-02-01)

The blood-stage dynamics of malaria infection with immune response
od: Jian Liu, i wsp.
Wydane: (2021-12-01)

The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.
od: Douglas, A, i wsp.
Wydane: (2011)